Crossmark

Design, synthesis, and biological evaluation of novel halogenated chlorido[N,N′-bis(salicylidene)-1,2-bis(3-methoxyphenyl)ethylenediamine]iron(III) complexes as anticancer agents

Crossref DOI link: https://doi.org/10.1007/s00775-024-02067-9

Published Online: 2024-08-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bernkop-Schnürch, Astrid Dagmar https://orcid.org/0009-0001-2632-8739
Huber, Klaus

Clauser, Armida

Cziferszky, Monika

Leitner, Daniel

Talasz, Heribert

Hermann, Martin

Hohloch, Stephan

Gust, Ronald

Kircher, Brigitte https://orcid.org/0000-0003-1624-2664
Funding

Funding for this research was provided by:

Austrian Science Fund (P31166)

University of Innsbruck and Medical University of Innsbruck
License Information

Text and Data Mining valid from 2024-08-12

Version of Record valid from 2024-08-12
More Information

Article History

Received: 19 January 2024

Accepted: 17 July 2024

First Online: 12 August 2024

Declarations

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below